Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma

Table 1

Clinical characteristics and MRI patterns of patients.

Variable	Good responders ()	Poor responders ()	value
(years)	14	15	0.328
Sex
Female	18	16	0.676
Male	35	26
	11	9	0.566
Treatment
BCD	43	34	0.593
VRD	10	8
D-S staging
II	6	5	0.588
III	47	37
ISS staging
I	12	7	0.643
II	18	13
III	23	22
R-ISS staging
I	10	7	0.834
II	33	25
III	10	10
MRI pattern
Normal	9	7	0.191
Focal	4	6
Diffuse	31	18
Focal and diffuse	4	9
Salt-and-pepper	5	2

BMPC: bone marrow plasma cells; D-S: Durie-Salmon staging system; ISS: International Staging System; R-ISS: Revised International Staging System.